How big is the Middle East & Africa Cell and Gene Therapy Market?

The Middle East & Africa Cell and Gene Therapy Market is valued at US$ 129.17 Million in 2023, it is projected to reach US$ 469.34 Million by 2031.

What is the CAGR for Middle East & Africa Cell and Gene Therapy Market by (2023 - 2031)?

As per our report Middle East & Africa Cell and Gene Therapy Market, the market size is valued at US$ 129.17 Million in 2023, projecting it to reach US$ 469.34 Million by 2031. This translates to a CAGR of approximately 17.5% during the forecast period.

What segments are covered in this report?

The Middle East & Africa Cell and Gene Therapy Market report typically cover these key segments- 类型（细胞疗法、基因疗法）服务（工艺开发、cGMP 制造、监管服务、生物测定服务）规模（商业化前/研发制造、商业规模制造）

What is the historic period, base year, and forecast period taken for Middle East & Africa Cell and Gene Therapy Market?

The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Cell and Gene Therapy Market report: 2025-2031 2023 2021-2023

Who are the major players in Middle East & Africa Cell and Gene Therapy Market?

The Middle East & Africa Cell and Gene Therapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include: Catalent Inc ; Charles River Laboratories International Inc ; F. Hoffmann-La Roche Ltd ; FUJIFILM Holdings Corp ; Lonza Group AG ; Lotte Corp ; Merck KGaA ; Takara Bio Inc ; Thermo Fisher Scientific Inc. ; WuXi AppTec Co Ltd

Who should buy this report?

The Middle East & Africa Cell and Gene Therapy Market report is valuable for diverse stakeholders, including: Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns. Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies. Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry. Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies. Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market. Essentially, anyone involved in or considering involvement in the Middle East & Africa Cell and Gene Therapy Market value chain can benefit from the information contained in a comprehensive market report.

中东和非洲细胞和基因治疗市场（主要地区、市场参与者、规模和份额）预测至 2031 年

2023 年中东和非洲细胞和基因治疗市场价值为 1.2917 亿美元，预计到 2031 年将达到 4.6934 亿美元；预计 2023 年至 2031 年的复合年增长率为 17.5%。

细胞和基因治疗制造服务自动化推动中东和非洲细胞和基因治疗市场发展

在细胞和基因治疗制造中采用自动化可以降低污染风险、提高一致性并降低生产成本。Lonza Cocoon 和 Miltenyi 的 CliniMACS Prodigy 系统是一些旨在提高单个系统内 CAR-T 工艺大多数连续单元操作自动化程度的设备。随着对细胞和基因治疗需求的增长，全球细胞和基因治疗产品的生产已经从小批量生产转向大批量生产。除了日益增多的研究活动外，细胞和基因治疗从学术和临床应用到商业化的演变也推动了商业化生产对自动化的需求。此外，政府机构正在采用细胞疗法生产的自动化技术，以提高国家生产能力。因此，预计细胞和基因治疗制造服务的自动化将在未来几年为中东和非洲的细胞和基因治疗市场带来新的趋势。

中东和非洲细胞和基因治疗市场概览

南非是一个发展中国家。在南非，细胞治疗项目的顺利实施可以减轻该国沉重的疾病负担；然而，细胞和基因治疗的高昂成本限制了南非患者获得这些疗法的机会。尽管南非的技术比其他非洲国家先进，但基因治疗的生产在南非仍然没有得到广泛应用。最大的问题是缺乏资金、人力资源和对治疗的认识。尽管南非政府努力支持生物技术产业，但细胞治疗尚未得到足够的重视。此外，科学和医学界高度创新，并专注于细胞和基因治疗。

中东和非洲细胞和基因治疗市场收入及预测至2031年（百万美元）

中东和非洲细胞和基因治疗市场细分

中东和非洲细胞和基因治疗市场按类型、服务、规模、最终用户和国家分类。

根据类型，中东和非洲细胞和基因治疗市场分为细胞治疗和基因治疗。细胞治疗细分市场在2023年占有较大的市场份额。此外，细胞治疗细分市场又细分为同种异体、自体、病毒载体。此外，基因治疗细分市场又分为非病毒载体和病毒载体。

在服务方面，中东和非洲细胞和基因治疗市场分为工艺开发、cGMP制造、监管服务和生物测定服务。 2023 年，工艺开发部分占据了最大的市场份额。

按规模划分，中东和非洲细胞和基因治疗市场分为商业化前/研发制造和商业规模制造。2023 年，商业化前/研发制造部分占据了更大的市场份额。

根据最终用户，中东和非洲细胞和基因治疗市场细分为合同研究组织、制药和生物制药公司以及学术和研究机构。2023 年，制药和生物制药公司部分占据了最大的市场份额。

按国家划分，中东和非洲细胞和基因治疗市场细分为南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区。 2023 年，南非占据了中东和非洲细胞和基因治疗市场的主导份额。

Catalent Inc、Charles River Laboratories International Inc、F. Hoffmann-La Roche Ltd、FUJIFILM Holdings Corp、Lonza Group AG、乐天公司、默克集团、Takara Bio Inc、赛默飞世尔科技公司和无锡药明康德股份有限公司是中东和非洲细胞和基因治疗市场的一些领先公司。

Middle East & Africa Cell and Gene Therapy Strategic Insights

Strategic insights for Middle East & Africa Cell and Gene Therapy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-cell-and-gene-therapy-market-strategic-framework.webp

Get more information on this report

Middle East & Africa Cell and Gene Therapy Report Scope

Report Attribute	Details
Market size in 2023	US$ 129.17 Million
Market Size by 2031	US$ 469.34 Million
Global CAGR (2023 - 2031)	17.5%
Historical Data	2025-2031
Forecast period	2021-2023
Segments Covered	By 类型（细胞疗法、基因疗法） By 服务（工艺开发、cGMP 制造、监管服务、生物测定服务） By 规模（商业化前/研发制造、商业规模制造） By 服务提供商（CDMO、CMO）
Regions and Countries Covered	中东和非洲（沙特阿拉伯、阿联酋、南非、中东和非洲其他地区）中东和非洲（沙特阿拉伯、阿联酋、南非、中东和非洲其他地区）
Market leaders and key company profiles	Catalent Inc Charles River Laboratories International Inc F. Hoffmann-La Roche Ltd FUJIFILM Holdings Corp Lonza Group AG Lotte Corp Merck KGaA Takara Bio Inc Thermo Fisher Scientific Inc. WuXi AppTec Co Ltd

Get more information on this report

Middle East & Africa Cell and Gene Therapy Regional Insights

The regional scope of Middle East & Africa Cell and Gene Therapy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.